• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

False-Positive Technetium-Pyrophosphate Scintigraphy in Two Patients With Hypertrophic Cardiomyopathy.

作者信息

Schafer Eric B, Tushak Zackary, Trankle Cory R, Rao Krishnasree, Cartagena Lorraine Colón, Shah Keyur B

机构信息

Division of Internal Medicine (E.B.S.), Virginia Commonwealth University Health System, Richmond, VA.

Division of Cardiology within Pauley Heart Center (Z.T., C.R.T., K.R., K.B.S.), Virginia Commonwealth University Health System, Richmond, VA.

出版信息

Circ Heart Fail. 2021 Mar;14(3):e007558. doi: 10.1161/CIRCHEARTFAILURE.120.007558. Epub 2021 Mar 5.

DOI:10.1161/CIRCHEARTFAILURE.120.007558
PMID:33663232
Abstract
摘要

相似文献

1
False-Positive Technetium-Pyrophosphate Scintigraphy in Two Patients With Hypertrophic Cardiomyopathy.两名肥厚型心肌病患者的假阳性焦磷酸盐锝闪烁扫描
Circ Heart Fail. 2021 Mar;14(3):e007558. doi: 10.1161/CIRCHEARTFAILURE.120.007558. Epub 2021 Mar 5.
2
(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.(99m)Tc-焦磷酸盐闪烁显像术鉴别轻链型心脏淀粉样变性与转甲状腺素蛋白相关家族性和老年性心脏淀粉样变性。
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):195-201. doi: 10.1161/CIRCIMAGING.112.000132. Epub 2013 Feb 11.
3
Interpreting technetium-99m pyrophosphate cardiac scans to diagnose transthyretin cardiac amyloidosis: Need for due diligence.解读锝-99m焦磷酸盐心脏扫描以诊断转甲状腺素蛋白心脏淀粉样变：需谨慎行事。
J Nucl Cardiol. 2021 Aug;28(4):1798-1801. doi: 10.1007/s12350-020-02181-6. Epub 2020 May 10.
4
Value of SPECT imaging in patients with TTR-amyloid: ratios are not enough.SPECT成像在转甲状腺素蛋白淀粉样变患者中的价值：仅靠比率是不够的。
J Nucl Cardiol. 2021 Apr;28(2):747-749. doi: 10.1007/s12350-019-01997-1. Epub 2019 Dec 19.
5
Optimal interpretation of Tc99m PYP in 2020: Avoiding the million-dollar mistake.2020年锝99m焦磷酸盐（Tc99m PYP）的最佳解读：避免百万美元的错误。
J Nucl Cardiol. 2021 Apr;28(2):503-506. doi: 10.1007/s12350-020-02503-8. Epub 2021 Jan 13.
6
A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting.一位心脏病学研究员从美国核医学与分子影像学会网络研讨会中获得的要点：99m锝焦磷酸钠（Tc 99m-PYP）评估转甲状腺素蛋白淀粉样变心肌病（ATTR心脏淀粉样变性）的病例——解读与报告
J Nucl Cardiol. 2021 Apr;28(2):604-609. doi: 10.1007/s12350-020-02516-3. Epub 2021 Mar 2.
7
Nuclear tracers for transthyretin cardiac amyloidosis: time to bone up?用于转甲状腺素蛋白心脏淀粉样变的核素示踪剂：是时候钻研一下了？
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):162-4. doi: 10.1161/CIRCIMAGING.113.000178.
8
Can Tc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis?锝-焦磷酸盐能否有助于早期检测无症状性变异型转甲状腺素蛋白淀粉样变性的心脏受累情况？
JACC Cardiovasc Imaging. 2017 Jun;10(6):713-714. doi: 10.1016/j.jcmg.2016.06.003. Epub 2016 Aug 24.
9
Serial Technetium Pyrophosphate Scintigraphy and Multimodality Assessments After Different Doses of Tafamidis for Variant Transthyretin Cardiac Amyloidosis.不同剂量他氟米地治疗变异型转甲状腺素蛋白心脏淀粉样变性后的系列焦磷酸锝闪烁扫描和多模态评估
Circ Heart Fail. 2023 Jan;16(1):e009595. doi: 10.1161/CIRCHEARTFAILURE.122.009595. Epub 2022 Dec 21.
10
Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.锝焦磷酸盐闪烁扫描术：转甲状腺素淀粉样变心肌病早期诊断的实用指南。
ESC Heart Fail. 2022 Feb;9(1):251-262. doi: 10.1002/ehf2.13693. Epub 2021 Nov 29.

引用本文的文献

1
Transthyretin cardiac amyloidosis: advances and ambiguities.转甲状腺素蛋白心脏淀粉样变性：进展与争议
Heart Fail Rev. 2025 Aug 29. doi: 10.1007/s10741-025-10552-9.
2
Concurrent Use of Tafamidis and Mavacamten for Transthyretin Cardiac Amyloidosis With Severe Outflow Tract Obstruction.塔非酰胺与马伐卡坦联用治疗伴有严重流出道梗阻的转甲状腺素蛋白心脏淀粉样变
JACC Case Rep. 2025 Aug 6;30(22):104495. doi: 10.1016/j.jaccas.2025.104495.
3
Mutations in the gene may lead to restrictive phenotype hypertrophic cardiomyopathy with poor prognosis: case report.
该基因的突变可能导致预后不良的限制性表型肥厚型心肌病：病例报告。
Eur Heart J Case Rep. 2025 Apr 10;9(5):ytaf180. doi: 10.1093/ehjcr/ytaf180. eCollection 2025 May.
4
Amyloids and the Heart: An Update.淀粉样蛋白与心脏：最新进展
J Clin Med. 2024 Nov 27;13(23):7210. doi: 10.3390/jcm13237210.
5
Pitfalls for the non-invasive diagnosis of wild-type transthyretin amyloid cardiomyopathy in a young adult: a case report.年轻成人野生型转甲状腺素蛋白淀粉样心肌病无创诊断的陷阱：一例报告
Eur Heart J Case Rep. 2023 Jul 13;7(7):ytad308. doi: 10.1093/ehjcr/ytad308. eCollection 2023 Jul.
6
Genotype-Phenotype Correlation of a Rare Transthyretin Variant Causing Amyloidosis.一种导致淀粉样变性的罕见转甲状腺素蛋白变体的基因型-表型相关性
CJC Open. 2022 Oct 1;4(12):1031-1035. doi: 10.1016/j.cjco.2022.09.005. eCollection 2022 Dec.
7
Multimodality assessments of wild-type transthyretin cardiac amyloidosis with no ventricular hypertrophy.无心室肥厚的野生型转甲状腺素蛋白心脏淀粉样变性的多模态评估。
ESC Heart Fail. 2023 Apr;10(2):1412-1417. doi: 10.1002/ehf2.14220. Epub 2022 Nov 6.
8
Fat biopsy from a pocket of cardiac implantable electronic device: An alternative diagnostic option for cardiac amyloidosis.心脏植入式电子设备囊袋脂肪活检：心脏淀粉样变性的一种替代诊断方法。
HeartRhythm Case Rep. 2022 May 18;8(8):554-557. doi: 10.1016/j.hrcr.2022.05.008. eCollection 2022 Aug.
9
Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia.亚洲诊断和监测转甲状腺素蛋白淀粉样心肌病患者的临床建议。
Clin Cardiol. 2022 Sep;45(9):898-907. doi: 10.1002/clc.23882. Epub 2022 Jul 6.
10
Autopsy in the era of advanced cardiovascular imaging.先进心血管成像时代的尸检。
Eur Heart J. 2022 Jul 7;43(26):2461-2468. doi: 10.1093/eurheartj/ehac220.